UNII Z8IX2SC1OH

PROPYLPARABEN

Unique Ingredient Identifier Z8IX2SC1OH is listed as a ingredient substance

• RN: 94-13-3
• EC: 202-307-7
• NCIT: C76730
• RXCUI: 34706
• PUBCHEM: 7175
• MF: C10H12O3
• INCHI KEY: QELSKZZBTMNZEB-UHFFFAOYSA-N
• SMILES: CCCOC(=O)C1=CC=C(O)C=C1

Dosage Forms

UNII Z8IX2SC1OH PROPYLPARABEN is commonly included in medications in the following forms.

Route	Dosage Form	Potency
AN,INFILTRATION	INJECTION	0.01 %
AURICULAR (OTIC)	SUSPENSION	0.001 %
BUCCAL	FILM	0.22 MG
BUCCAL	FILM, SOLUBLE	0.18 MG
IM - IV	INJECTABLE	0.015 %
IM - IV	INJECTION	0.2 %
IM - IV	POWDER, FOR INJECTION SOLUTION	0.04 %
IM - IV	SOLUTION	0.016 %
IM - IV - SC	INJECTION	20 %
IM - SC	INJECTION	0.02 %
INTRA-ARTERIAL	INJECTION	NA
INTRA-ARTICULAR	INJECTION	0.16 %
INTRABURSAL	INJECTION	0.02 %
INTRALESIONAL	INJECTION	0.02 %
INTRAMUSCULAR	INJECTABLE	0.02 %W/V
INTRAMUSCULAR	INJECTION	0.16 %
INTRAMUSCULAR	INJECTION, SOLUTION	0.2 MG/1ML
INTRAMUSCULAR	INJECTION, SUSPENSION	0.015 %
INTRAMUSCULAR	SOLUTION, INJECTION	NA
INTRAMUSCULAR	SUSPENSION	0.02 %
INTRAMUSCULAR	SUSPENSION, INJECTION	0.15 MG/1ML
INTRAMUSCULAR	SUSPENSION, INJECTION	0.015 %W/V
INTRASYNOVIAL	INJECTION	NA
INTRATUMOR	INJECTION	0.02 %
INTRAVASCULAR	INJECTION	0.03 %
INTRAVENOUS	INJECTABLE	0.08 %
INTRAVENOUS	INJECTION	0.1 %
INTRAVENOUS	INJECTION, SOLUTION	0.2 MG/1ML
INTRAVENOUS	LIQUID, WATER, STERILE, FOR INJECTION	0.02 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION	0.08 %
INTRAVENOUS	SOLUTION, INJECTION	0.02 %
INTRAVENOUS INFUSION	INJECTION	0.2 MG/1ML
IV - SC	INJECTION	0.15 MG/1ML
IV - SC	INJECTION	0.02 %
IV(INFUSION)	INJECTION	0.056 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION	0.04 %
NASAL	SOLUTION	0.017 %
NASAL	SOLUTION, SPRAY	0.02 %
NASAL	SPRAY, METERED	0.3 %
NERVE BLOCK	INJECTION	0.035 %
OPHTHALMIC	OINTMENT	0.01 %
OPHTHALMIC	SOLUTION	0.015 %
OPHTHALMIC	SOLUTION, DROPS	0.011 %
OPHTHALMIC	SUSPENSION	0.01 %
OPHTHALMIC	SUSPENSION, DROPS	0.01 %
ORAL	CAPSULE	0.21 MG
ORAL	CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL	0.081 MG
ORAL	CAPSULE, COATED, SOFT GELATIN	0.053 MG
ORAL	CAPSULE, HARD GELATIN	NA
ORAL	CAPSULE, SOFT GELATIN	0.12 MG
ORAL	CAPSULE, SUSTAINED ACTION	0.22 MG
ORAL	CONCENTRATE	2.5 MG/5ML
ORAL	DROPS	NA
ORAL	EMULSION	NA
ORAL	LIQUID	0.2 MG/1ML
ORAL	POWDER	0.04 %
ORAL	POWDER, FOR ORAL SOLUTION	0.15 MG
ORAL	POWDER, FOR ORAL SUSPENSION	0.08 %W/W
ORAL	POWDER, FOR SOLUTION	0.16 MG/1ML
ORAL	POWDER, FOR SUSPENSION	4 MG/5ML
ORAL	SOLUTION	100 MG
ORAL	SOLUTION	3 mg/15 mL
ORAL	SOLUTION	1 MG/5ML
ORAL	SOLUTION	0.1 MG/1ML
ORAL	SOLUTION	0.017 %W/W
ORAL	SOLUTION, CONCENTRATE	0.2 MG/1ML
ORAL	SOLUTION, ELIXIR	3 MG/15ML
ORAL	SOLUTION, LIQUID	0.2 MG/1ML
ORAL	SOLUTION, SYRUP	1 MG/1ML
ORAL	SUSPENSION	200 MG/5ML
ORAL	SUSPENSION	1.95 MG/15 ML
ORAL	SUSPENSION	0.32 mg/1mL
ORAL	SUSPENSION, EXTENDED RELEASE	20 %
ORAL	SUSPENSION, LIQUID	3 MG/5ML
ORAL	SUSPENSION, SUSTAINED ACTION	1.5 MG/5ML
ORAL	SYRUP	200 MG/5ML
ORAL	TABLET	0.2 MG
ORAL	TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	0.14 MG
ORAL	TABLET, COATED	0.002 MG
ORAL	TABLET, FILM COATED	0.04 MG
ORAL	TABLET, SUSTAINED ACTION	0.12 MG
PARENTERAL	INJECTION	0.02 %
RECTAL	AEROSOL, METERED	0.009 %
RECTAL	LIQUID	0.015 %
RECTAL	SOLUTION	0.015 %
RECTAL	SUSPENSION	0.034 %
SOFT TISSUE	INJECTION	0.02 %
SUBCUTANEOUS	INJECTION	0.03 %
SUBCUTANEOUS	SUSPENSION, INJECTION	0.023 %
TOPICAL	CREAM	0.4 %W/W
TOPICAL	CREAM, AUGMENTED	0.1 %W/W
TOPICAL	CREAM, EMULSION, SUSTAINED RELEASE	0.1 %W/W
TOPICAL	EMULSION	0.06 %W/W
TOPICAL	EMULSION, AEROSOL FOAM	0.011 %W/W
TOPICAL	EMULSION, CREAM	5.25 %W/W
TOPICAL	EMULSION, LOTION	0.06 %W/W
TOPICAL	GEL	0.05 %W/W
TOPICAL	JELLY	0.03 %W/V
TOPICAL	LOTION	0.2 %W/W
TOPICAL	OINTMENT	0.2 %W/W
TOPICAL	PATCH	NA
TOPICAL	PATCH, CONTROLLED RELEASE	NA
TOPICAL	SHAMPOO	0.03 %W/W
TOPICAL	SOLUTION	0.033 %W/W
TOPICAL	SPRAY	0.8 %W/W
URETERAL	SOLUTION	NA
URETHRAL	INJECTION	0.02 %
URETHRAL	JELLY	0.03 %
VAGINAL	CREAM, EMULSION, SUSTAINED RELEASE	0.05 %
VAGINAL	EMULSION, CREAM	0.1 %
VAGINAL	GEL	0.02 %
VAGINAL	SUPPOSITORY	NA